Archive for the ‘neuroscience’ category: Page 753
Apr 24, 2019
Genetically modified virus may shrink incurable brain cancers
Posted by Paul Battista in categories: bioengineering, biotech/medical, genetics, neuroscience
By Michael Le Page
People with incurable melanomas and brain or breast cancers are to get injections of tumour-fighting viruses.
The trial will test the safety of a virus that has been engineered to shrink tumours – an approach that holds promise for a range of cancers, including deadly brain tumours.
Continue reading “Genetically modified virus may shrink incurable brain cancers” »
Apr 24, 2019
New device translates brain activity into speech. Here’s how
Posted by Genevieve Klien in category: neuroscience
The research may one day give voice to people who lost speech from neurological disorders.
Apr 24, 2019
Synthetic speech generated from brain recordings
Posted by Mike Ruban in categories: biotech/medical, computing, neuroscience
A state-of-the-art brain-machine interface created by UC San Francisco neuroscientists can generate natural-sounding synthetic speech by using brain activity to control a virtual vocal tract—an anatomically detailed computer simulation including the lips, jaw, tongue, and larynx. The study was conducted in research participants with intact speech, but the technology could one day restore the voices of people who have lost the ability to speak due to paralysis and other forms of neurological damage.
Stroke, traumatic brain injury, and neurodegenerative diseases such as Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) often result in an irreversible loss of the ability to speak. Some people with severe speech disabilities learn to spell out their thoughts letter-by-letter using assistive devices that track very small eye or facial muscle movements. However, producing text or synthesized speech with such devices is laborious, error-prone, and painfully slow, typically permitting a maximum of 10 words per minute, compared to the 100–150 words per minute of natural speech.
Continue reading “Synthetic speech generated from brain recordings” »
Apr 24, 2019
A new clue in the mystery of ALS, frontotemporal dementia
Posted by Quinn Sena in categories: biotech/medical, genetics, neuroscience
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis (ALS) or frontotemporal dementia.
ALS, a rare but devastating disorder that’s also known as Lou Gehrig’s disease, attacks the body’s nerve cells, resulting in progressive muscle weakness as the neurons degenerate over time. There is no cure. People with ALS eventually lose their strength and the ability to move their arms, legs and body.
About a third of those with ALS also develop frontotemporal dementia (FTD), a destruction of neurons in the brain that causes profound personality changes and disability. The two diseases are similar in both pathology and genetics. FTD tends to affect people earlier than Alzheimer’s disease, the most common type of dementia.
Continue reading “A new clue in the mystery of ALS, frontotemporal dementia” »
Apr 24, 2019
Researchers identify neurotransmitter that helps cancers progress
Posted by Quinn Sena in categories: biotech/medical, neuroscience
Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical “messengers” that transmit impulses from neurons to other target cells.
The work, described in the April 9 issue of the journal Cell Reports, found that this neurotransmitter, called N-acetyl-aspartyl-glutamate (NAAG) NAAG is more abundant in cancers with a tendency to grow and spread rapidly—or so-called higher grade cancers—than in lower grade tumors, making it a potential marker for tumor progression or regression during cancer therapy, the researchers say. The experiments also demonstrated that NAAG is a source of glutamate, a chemical that cancer cells use as building blocks to survive, in tumors that express an enzyme called glutamate carboxypeptidase II (GCPII). The group also discovered that stopping the GCPII from being active by using a drug called 2-PMPA to treat human ovarian tumors implanted in ovaries of mice, reduced tumor weights and glutamate concentrations.
Apr 24, 2019
This Brainless Slime Learns And Remembers
Posted by Quinn Sena in category: neuroscience
O.o its prob gonna eat me someday :0.
Slime mould might easily be one of the strangest life forms on our planet. They are neither plants, animals, nor fungi, but various species of complex, single-celled amoebas of the protist kingdom. Sometimes they form colonies able to grow, move, and even exhibit a strange kind of intelligence.
Even without a nervous system, they are able to learn about substances they encounter, retaining that knowledge and even communicating it to other slime moulds. Now a team of scientists at the French National Centre for Scientific Research (CNRS) has figured out how: slime moulds actually absorb the substance into their veins.
Continue reading “This Brainless Slime Learns And Remembers” »
Apr 24, 2019
Scientists Unveil a ‘Brain Decoder’ That Turns Neural Activity Into Speech
Posted by Quinn Sena in categories: biological, information science, neuroscience
The spoken word is a powerful tool, but not all of us have the ability to use it, either due to biology or circumstances. In such cases, technology can bridge the gap — and now that gap is looking shorter than ever, with a new algorithm that turns messages meant for your muscles into legible sounds.
Converting the complex mix of information sent from the brain to the orchestra of body parts required to transform a puff of air into meaningful sound is by no means a simple feat.
Continue reading “Scientists Unveil a ‘Brain Decoder’ That Turns Neural Activity Into Speech” »
Apr 24, 2019
Brain Implant Device Allows People With Speech Impairments to Communicate With Their Minds
Posted by Klaus Baldauf in categories: computing, neuroscience
Apr 24, 2019
Injecting CRISPR into fetal brain may correct autism mutations
Posted by Quinn Sena in categories: biotech/medical, genetics, neuroscience
Researchers are edging closer to a therapy for Angelman syndrome that involves injecting molecules that can edit genes into the fetal brain. They have already succeeded in mice and say the approach could eventually treat people with the syndrome.
The work is of high interest because a similar strategy could also work for other genetic conditions linked to autism.
But the prospect of injecting molecules into fetal brains poses ethical questions, experts caution.
Continue reading “Injecting CRISPR into fetal brain may correct autism mutations” »